Corporate Members





Latest News

Florida Cancer Specialists’ Physician Named FLASCO President for Second Term

Posted April 26, 2016

Thank you to Florida Cancer Specialists for recognizing Florida Society of Clinical Oncology’s President on his second term. We greatly appreciate Dr. Michael Diaz’s dedication and commitment to FLASCO, and would like to congratulate Dr. Diaz on a very successful first term. Dr. Michael Diaz Continues Leadership of Statewide Cancer Advocacy Organization Florida Cancer Specialists...

Three FLASCO Members Nominated for Leukemia & Lymphoma Society’s Man/Woman of the Year

Posted April 25, 2016

Florida Cancer Specialists & Research Institute and FLASCO are pleased to announce that Dr. Julia Cogburn, Dr. Vipul Patel andDr. Meera Iyengar have been nominated by several local Florida chapters of the Leukemia & Lymphoma Society (LLS) as Man/Woman of the Year for 2016. After an intensive nominating and vetting process, these outstanding physicians and...

Fellows Travel Awards

Posted April 25, 2016

FLASCO proudly awarded 5 Travel Awards to the following FLASCO Member Fellows. Erica Takimoto, DO, from Florida Hospital Gynecologic Oncology; Jennifer Crozier, MD, from Mayo Clinic Florida; Susmitha Apuri, MD, from Moffitt Cancer Center; Bhagirathbhai Dholaria, MBBS, from Mayo Clinic Florida; and Sharon Robertson, MD, from Moffitt Cancer Center. FLASCO supports the Oncologists of the...

FLASCO Members Visit the Hill

Posted April 25, 2016

Yesterday, FLASCO Members, Dr. Alan Marks and Dr. Morganna Freeman, along with Matthew Martello of Johnson & Johnson, participated in Biotechnology Innovation Organization’s Fly-In Legislative Day. They were able to meet with key members of Congress and their staff. They met with Representative Kathy Castor, Representative David Jolly, Representative Daniel Webster, and Representative Alan Grayson....

FDA Clarifies Compounding Rules

Posted April 25, 2016

The Food and Drug Administration issued three draft guidance documents on Friday that answer providers’ and pharmacists’ burning questions about drug compounding standards. The proposed rules clarify the amount of drugs that providers can compound without a prescription, set requirements for health system compounding pharmacies and clarify how large-scale compounding sites known as “outsourcing facilities” may be...

Who’s Online

There are no users currently online